Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation

Clinical Pharmacology and Therapeutics

Volumn 69, Issue 4, 2001, Pages 238-244

  Kubli, Sandrine ^a   Feihl, François ^a   Waeber, Bernard ^a,b  

^a PSI   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ATENOLOL; NEBIVOLOL;

ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DOPPLER FLOWMETRY; DRUG POTENTIATION; FOREARM BLOOD FLOW; HEART RATE; HUMAN; HUMAN EXPERIMENT; IONTOPHORESIS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN BLOOD FLOW; SKIN TEMPERATURE; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

ACETYLCHOLINE; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BENZOPYRANS; BLOOD PRESSURE; CROSS-OVER STUDIES; DRUG SYNERGISM; ETHANOLAMINES; HEART RATE; HUMANS; IONTOPHORESIS; LASER-DOPPLER FLOWMETRY; MALE; RANDOM ALLOCATION; REGIONAL BLOOD FLOW; SKIN; TEMPERATURE; VASODILATION; VASODILATOR AGENTS;

EID: 0035033885     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2001.114670     Document Type: Article

References (26)

1. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension
2. Vasodilation to acetylcholine in primary and secondary forms of human hypertension
3. Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis
4. Impaired coronary blood now response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions
5. Endothelial function in chronic congestive heart failure
6. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure
7. Endothelial function as an end-point in interventional trials; concepts, methods and current data
8. Endothelial dysfunction: Clinical implications
9. The receptor binding profile of the new anti-hypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers
10. Nebivolol is devoid of intrinsic sympathomimetic activity
11. Nebivolol induces endothelium-dependent relaxations of canine coronary arteries
12. Nebivolol vasodilates human forearm vasculature: Evidence for an L-arginine/ NO-dependent mechanism
13. The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension
14. Reproductibility of laser Doppler imaging of skin blood flow as a tool to assess endothelial function
15. Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: Possible mechanisms
16. Nitric oxide mediated venodilator effects of nebivolol
17. Pharmacology of nebivolol
18. Cardiovascular effects of d-nebivolol and its enantiomers: A comparison with those of atenolol
19. Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney
20. Nebivolol vs atenolol and placebo in essential hypertension: A double-blind randomised trial
21. Bioavailability of atenolol formulations
22. Dose-dependent beta-sympatholytic activity of nebivolol in comparison with atenolol
23. Blockade of the ATP-sensitive potassium channel modulares reactive hyperemia in the canine coronary circulation
24. Role of adenine nucleotides, adenosine, and inorganic phosphate in the regulation of skeletal muscle blood flow
25. Endogenous prostaglandins as local regulators of blood flow in man: Effect of indomethacin on reactive and functional hyperaemia
26. Evidence for sensory nerve involvement in cutaneous reactive hyperemia in humans